INmune Bio Inc.'s Chief Scientific Officer, Mark Lowdell, Ph.D. to Present Plenary Talk at International Society of Cell & Gene Therapy

Presidential Plenary Lecture to be Presented Wednesday, May 31 at the ICST Opening Session BOCA RATON, Fla., May 24, 2023 --  INmune Bio Inc. announces that Mark Lowdell,... | June 11, 2023

Related Keywords

Paris ,France General ,France ,Inmune Bio ,Jason Nelson ,David Moss ,Mark Lowdell ,Md Inmune Bio ,Matt Rettig ,International Society Of Cell ,Prostate Cancer Program ,Inmune Bio Inc ,David Geffen School Of Medicine ,Company Current Reports On Form ,Drug Administration ,Nasdaq ,Company Annual Report On Form ,Exchange Commission ,Company Quarterly Reports On Form ,Globe Newswire Inmune Bio Inc ,Presidential Plenary ,Presented Wednesday ,Presidential Symposium ,International Society ,Gene Therapy ,Immune Effector Cell Therapies ,Tumor Primed Memory ,Clinical Trials ,Natural Killer ,Investigational New Drug Application ,Medical Director ,David Geffen School ,Jonsson Comprehensive Cancer ,Dominant Negative Tumor Necrosis Factor ,Mild Alzheimer ,Mild Cognitive Impairment ,Natural Killer Cell Priming Platform ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,